|
Pfizer to Acquire Wyeth Creating the World's Premier Biopharmaceutical Company Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) on January 26 announced that they have entered into a definitive merger agreement under which Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at $50.19 per share, or a total of approximately $68 billion. The Boards of Directors of both companies have approved the combination. Source: Pfizer Permalink: http://www.sflorg.com/comm_center/announcements/p833_21.html Time Stamp: 1/26/2009 at 10:49:12 PM UTC |
Scientific
Frontline®
RSS
Feeds
Scientific
Frontline®
The
Comm Center
The
E.A.R.®
World
News Report
Stellar
Nights®
Cassini
Gallery
Mars
Gallery
Missions
Gallery
Observatories
Gallery
Space
Weather Alerts
Events
Directors
Chair
Scientific Frontline® Is supported in part by “Readers Like You” |
